Open AccessSafety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial
Author(s) -
Xiaojiao Li,
Yusi Liu,
Hanxin Yao,
Meng Wang,
Lei Gao,
Jinfeng Lou,
John Mao,
Wenqiang Wu,
Yixin Zhou,
Yanan Tang,
Wenhao Yan,
Yanbin Hu,
Charles Z. Ding,
Shuhui Chen,
Junqi Niu,
Yanhua Ding
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00094-22
Subject(s) - tolerability , pharmacokinetics , placebo , adverse effect , medicine , dosing , nausea , pharmacology , gastroenterology , vomiting , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom